IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trial
IL-6 敲低抗 CD19 CAR-T 细胞 (ssCART-19) 用于复发或难治性急性淋巴细胞白血病患者:I 期试验
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01397-4
Xue, Sheng-Li; Liu, Mei-Jing; Qian, Chong-Sheng; Chen, Su-Ning; Qiu, Hui-Ying; Kang, Li-Qing; Dai, Hai-Ping; Gong, Wen-Jie; Chen, Li-Yun; Yao, Zhen; Xu, Ming-Zhu; Zhou, Hai-Xia; Yang, Xiao-Fei; Wu, Qian; Dou, Xue-Qing; Zhang, Jian; Liu, Yin; Cui, Qing-Ya; Li, Zheng; Xu, Yang; Qiao, Man; Zhang, Tong-Tong; Tan, Jing-Wen; Xu, Nan; Li, Ming-Hao; Yu, Zhou; Lou, Xiao-Yan; Wang, Wei; Zhu, Hong-Jia; Qin, Lu; Yu, Lei; Tang, Xiao-Wen; Wu, De-Pei